ArticleCancer management and research2019

Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with

Qianwen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.